Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samruddhi Ranmale

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vaccines|December 23, 2022
Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking SurgeryPavan Kumar, Samruddhi Ranmale, Hemant Tongaonkar, et al.
Results and Problems in Cell Differentiation|June 1, 2026
Podosomes and Mechanical ForceMalgorzata Kloc, Souhail A Thabet, Samruddhi Ranmale, et al.
Indian Journal of Medical Microbiology|May 21, 2021
Human papillomavirus infection: Is it associated with epithelial ovarian cancer?Pavan Kumar, Samruddhi Ranmale, Hemant Tongaonkar, et al.
Wiley Interdisciplinary Reviews. RNA|May 4, 2024
Noncoding RNAs: Emerging regulators of behavioral complexitySanovar Dayal, Divya Chaubey, Dheeraj Chandra Joshi, et al.
Frontiers in Immunology|April 16, 2026
Chemotherapy driven alterations in NK cell receptors and ligands in high grade serous ovarian cancerPavan Kumar, Samruddhi Ranmale, Sanket Mehta, et al.
Asia-Pacific Journal of Clinical Oncology|December 31, 2025
Role of EpCAM-Positive Exosomes in Ovarian Cancer: MiRNA Signatures of Chemoresistance and Disease ProgressionSamruddhi Ranmale, Pavan Kumar, Hemant Tongaonkar, et al.
Frontiers in Oncology|September 8, 2025
Chemotherapy-induced alterations in miRNA expression and their prognostic implications in ovarian cancerSamruddhi Ranmale, Pavan Kumar, Hemant Tongaonkar, et al.
Journal of Ovarian Research|June 15, 2023
Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancerPavan Kumar, Samruddhi Ranmale, Sanket Mehta, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccines|December 23, 2022
Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking SurgeryPavan Kumar, Samruddhi Ranmale, Hemant Tongaonkar, et al.
Results and Problems in Cell Differentiation|June 1, 2026
Podosomes and Mechanical ForceMalgorzata Kloc, Souhail A Thabet, Samruddhi Ranmale, et al.
Indian Journal of Medical Microbiology|May 21, 2021
Human papillomavirus infection: Is it associated with epithelial ovarian cancer?Pavan Kumar, Samruddhi Ranmale, Hemant Tongaonkar, et al.
Wiley Interdisciplinary Reviews. RNA|May 4, 2024
Noncoding RNAs: Emerging regulators of behavioral complexitySanovar Dayal, Divya Chaubey, Dheeraj Chandra Joshi, et al.
Frontiers in Immunology|April 16, 2026
Chemotherapy driven alterations in NK cell receptors and ligands in high grade serous ovarian cancerPavan Kumar, Samruddhi Ranmale, Sanket Mehta, et al.
Asia-Pacific Journal of Clinical Oncology|December 31, 2025
Role of EpCAM-Positive Exosomes in Ovarian Cancer: MiRNA Signatures of Chemoresistance and Disease ProgressionSamruddhi Ranmale, Pavan Kumar, Hemant Tongaonkar, et al.
Frontiers in Oncology|September 8, 2025
Chemotherapy-induced alterations in miRNA expression and their prognostic implications in ovarian cancerSamruddhi Ranmale, Pavan Kumar, Hemant Tongaonkar, et al.
Journal of Ovarian Research|June 15, 2023
Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancerPavan Kumar, Samruddhi Ranmale, Sanket Mehta, et al.
Pageof 1